1. Scrip
  2. >>Business

Progress In Pharma’s Slow Battle Against Respiratory Syncytial Virus

AZ and Sanofi’s Antibody Success Against The Often Deadly Infection

 
• By Andrew McConaghie

Pfizer is up against AstraZeneca and Sanofi in developing competing approaches to tackling the unmet need in respiratory syncytial virus (RSV). But earlier failures mean all players will need much more data to sway regulators.

Boy_Inhaler
Respiratory synctial virus (RSV) is one of the biggest causes of hospitalization and death in infants worldwide.

The world’s focus on finding a vaccine against SARS-CoV-2, and the rapid progress already seen is throwing into sharp relief the slow, setback-strewn story of another often deadly infection: respiratory syncytial virus (RSV).

RSV is familiar to new parents: 90% of infants are infected with the virus within the first two years of life, and it the most common

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

Switzerland Biopharma To Stay Strong Despite More Cash Going To US And China

 
• By Kevin Grogan

The sector is continuing to show resilience despite financial and market challenges.

Pipeline Watch: Thirteen Approvals And Ten Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Executives On The Move: Five CEOs, Three CFOs And Two CMOs Among This Week’s Changes

Recent moves in the industry include changes at the top at Immunovant, Zymeworks and Cassava Sciences, among others, plus Zealand Pharma acquires chief scientific officer from Eli Lilly.